Breaking News Instant updates and real-time market news.

SNY

Sanofi

$47.93

-0.0378 (-0.08%)

, MRK

Merck

$62.30

-0.54 (-0.86%)

15:33
08/08/17
08/08
15:33
08/08/17
15:33

Sanofi announces filing of patent infringement suit against Merck

Sanofi (SNY) announced that it filed a patent infringement suit against Merck (MRK) on August 8 in the United States District Court for the District of New Jersey. In its suit Sanofi alleges infringement of two patents. The suit was triggered by a notification received from Merck in late June, in which Merck stated that it had filed an NDA with FDA for an insulin glargine vial drug product. Merck also stated that its NDA included a paragraph IV certification challenging all of the Sanofi patents then listed in the FDA Orange Book for Sanofi's Lantus and Lantus SoloStar products.

SNY

Sanofi

$47.93

-0.0378 (-0.08%)

MRK

Merck

$62.30

-0.54 (-0.86%)

  • 28

    Aug

  • 22

    Sep

SNY Sanofi
$47.93

-0.0378 (-0.08%)

07/10/17
PIPR
07/10/17
NO CHANGE
Target $126
PIPR
Overweight
Alnylam shares overreacting to ALT elevations in OLE data, says Piper Jaffray
Alnylam (ALNY) and partner Sanofi (SNY) presented new Phase II open-label extension study data on 33 hemophilia patients being treated with fitusiran and reported that eleven patients reported asymptomatic ALT increases, up from three observed in its ASH meeting update, noted Piper Jaffray analyst Edward Tenthoff. However, he thinks the stock is overreacting, as the liver enzyme elevations were asymptomatic and largely reversed within one month, he tells investors. Tenthoff, who also sees the efficacy data as encouraging, reiterates his Overweight rating and $126 price target on Alnylam shares.
07/14/17
WELS
07/14/17
NO CHANGE
Target $41
WELS
Outperform
Wells says smallpox vaccine deal an 'excellent fit' for Emergent BioSolutions
Wells Fargo analyst David Maris said Emergent BioSolutions' (EBS) deal to acquire the ACAM2000 smallpox vaccine business of Sanofi (SNY) is "an excellent fit" and he is "encouraged" by its ability to identify and make a deal for such a "solid target." Maris keeps an Outperform rating and $41 price target on Emergent BioSolutions.
07/31/17
PIPR
07/31/17
NO CHANGE
Target $557
PIPR
Overweight
Regeneron indicated lower after Sanofi earnings report, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff says shares of Regeneron (REGN) are indicated lower after partner Sanofi (SNY) reported Q2 U.S. Dupixent sales of $30M in adults with atopic dermatitis. This was essentially in line with the consensus estimate of $33M, Tenthoff tells investors in a research note. He adds that over 5,100 physicians have prescribed and over 13,000 atopic dermatitis patients have been prescribed Dupixent as of July 26. The analyst views the launch stats as impressive and reiterates an Overweight rating on Regeneron with a $557 price target.
07/31/17
ADAM
07/31/17
NO CHANGE
Target $522
ADAM
Buy
Dupixent authorization approval rate outweighs Q2 miss, says Canaccord
Regeneron (REGN) partner Sanofi (SNY) reported a "very high" 73%-83% prior authorization approval rate for Dupixent in Q2, which Canaccord analyst John Newman said outweighs the fact that sales for the drug at $30.6M were slightly below the $33M consensus forecast. The analyst, who sees rapid payor acceptance of Dupixent as "much more crucial" than the initial quarterly revenue, keeps a Buy rating and $522 price target on Regeneron shares.
MRK Merck
$62.30

-0.54 (-0.86%)

07/27/17
GSCO
07/27/17
NO CHANGE
GSCO
Merck could trade up $5 following AstraZeneca MYSTIC failure, says Goldman Sachs
Goldman analyst Jami Rubin expects Merck (MRK) to trade up approximately $5 based on sentiment following AstraZeneca's MYSTIC failure as it partially de-risks longer-term estimates for Keytruda. As a result, the analyst raised Merck's Keytruda sales estimates by $600M in 2018 and $1B in 2019 and beyond, increasing earnings estimates by 14c-20c, and raising his price target on shares to $74 from $70. Rubin cautions that long-term estimates could be at risk if other competitor trials are successful. The analyst rates Merck a Neutral.
07/27/17
FBCO
07/27/17
NO CHANGE
FBCO
Merck unlikely to buy PARP company after Astra deal, says Credit Suisse
Credit Suisse analyst Alethia Young believes Merck (MRK) is unlikely to acquire a PARP inhibitor company like Tesaro (TSRO) or Clovis (CLVS) after inking an immuno-oncology deal with AstraZeneca (AZN).
07/27/17
JANY
07/27/17
NO CHANGE
Target $107
JANY
Buy
PARP deals may make Clovis more attractive buyout candidate, says Janney
The partnerships announced today between AstraZeneca (AZN) and Merck (MRK) as well as Tesaro (TSRO) and Takeda highlight pharma's willingness to expand on PARP's, Janney analyst Debjit Chattopadhyay tells investors in a research note. Clovis' (CLVS) Rubraca is now the only unencumbered PARP and is "far cheaper" on a relative valuation basis than peer Tesaro, the analyst adds. He believes Clovis could now become a more compelling takeover candidate. Chattopadhyay has a Buy rating on the shares with a $107 price target. The stock in midday trading is up 7%, or $5.90, to $93.33.
07/28/17
RHCO
07/28/17
NO CHANGE
RHCO
Merck, AstraZeneca deal positive, says SunTrust
After Merck (MRK) paid $1.6B upfront for access to Astrazeneca's (AZN) PARP inhibitor, Lynparza and another drug, SunTrust analyst John Boris says that the deal "makes strategic/financial sense and validates the PARP inhibitor class." He adds that the companies are "ideally positioned" to leverage a combination of IO and PARP therapies. The analyst reiterates a $73 price target and a Buy rating on Merck.

TODAY'S FREE FLY STORIES

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
09/18/18
09/18
13:16
09/18/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STL

Sterling Bancorp

$21.95

-0.2 (-0.90%)

13:13
09/18/18
09/18
13:13
09/18/18
13:13
Conference/Events
Sterling Bancorp management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 24

    Sep

  • 29

    Oct

ACBFF

Aurora Cannabis

$0.00

(0.00%)

13:13
09/18/18
09/18
13:13
09/18/18
13:13
Hot Stocks
Aurora Cannabis reports additional supply arrangements with Canadian provinces »

Aurora Cannabis announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCSA

Comcast

$37.73

0.765 (2.07%)

, CMCSK

Comcast

$0.00

(0.00%)

13:11
09/18/18
09/18
13:11
09/18/18
13:11
Periodicals
Emmy show on NBC ties for lowest viewership in Emmy history, CNN says »

Last night's 70th…

CMCSA

Comcast

$37.73

0.765 (2.07%)

CMCSK

Comcast

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PDD

Pinduoduo

$24.51

0.14 (0.57%)

, BABA

Alibaba

$156.19

-2.57 (-1.62%)

13:11
09/18/18
09/18
13:11
09/18/18
13:11
Periodicals
Pinduoduo's growth in transactions has slowed, The Information reports »

New data from…

PDD

Pinduoduo

$24.51

0.14 (0.57%)

BABA

Alibaba

$156.19

-2.57 (-1.62%)

JD

JD.com

$25.64

-0.08 (-0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 28

    Oct

SEDG

SolarEdge

$42.10

0.05 (0.12%)

, ENPH

Enphase Energy

$4.26

0.39 (10.08%)

13:07
09/18/18
09/18
13:07
09/18/18
13:07
Recommendations
SolarEdge, Enphase Energy, ABB analyst commentary  »

Latest tariffs…

SEDG

SolarEdge

$42.10

0.05 (0.12%)

ENPH

Enphase Energy

$4.26

0.39 (10.08%)

ABB

ABB

$23.97

-0.05 (-0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

TSLA

Tesla

$278.00

-16.78 (-5.69%)

13:07
09/18/18
09/18
13:07
09/18/18
13:07
Periodicals
Tesla says it received 'voluntary request' for documents from DOJ »

In a statement provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 29

    Oct

SPWR

SunPower

$7.53

0.95 (14.44%)

13:05
09/18/18
09/18
13:05
09/18/18
13:05
Options
SunPower call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOB

Live Oak Bancshares

$28.65

0.1 (0.35%)

13:02
09/18/18
09/18
13:02
09/18/18
13:02
Hot Stocks
Live Oak Bank says headquarters will remain closed 'until further notice' »

The company said, "…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLAB

Mesa Labs

$180.50

-2.5 (-1.37%)

13:02
09/18/18
09/18
13:02
09/18/18
13:02
Conference/Events
Mesa Labs management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

KTOV

Kitov Pharmaceuticals

$1.90

-0.03 (-1.55%)

13:01
09/18/18
09/18
13:01
09/18/18
13:01
Hot Stocks
Kitov Pharmaceuticals says SEC commenced action to enforce subpoena »

Kitov Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UWN

Nevada Gold

$2.32

-0.01 (-0.43%)

13:00
09/18/18
09/18
13:00
09/18/18
13:00
Hot Stocks
Breaking Hot Stocks news story on Nevada Gold »

Nevada Gold trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSRGY

Nestle

$0.00

(0.00%)

, UL

Unilever; also tag UN

$55.84

-0.09 (-0.16%)

12:55
09/18/18
09/18
12:55
09/18/18
12:55
Periodicals
Nestle, Unilever, Coke submit offers for GSK Indian Horlicks unit, Reuters says »

Nestle (NSRGY), Unilever…

NSRGY

Nestle

$0.00

(0.00%)

UL

Unilever; also tag UN

$55.84

-0.09 (-0.16%)

UN

Unilever; also tag UL

$56.31

-0.02 (-0.04%)

KO

Coca-Cola

$46.08

-0.24 (-0.52%)

GSK

GlaxoSmithKline

$39.49

0.285 (0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 28

    Oct

  • 03

    Mar

ERIC

Ericsson

$8.70

0.155 (1.82%)

12:50
09/18/18
09/18
12:50
09/18/18
12:50
Options
Call buyers dialed in to Ericsson as shares tick higher »

Call buyers dialed in to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCD

McDonald's

$158.16

0.01 (0.01%)

12:48
09/18/18
09/18
12:48
09/18/18
12:48
Periodicals
Female McDonald's workers stage walkouts over sexual harassment, Eater says »

Female employees at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

UWN

Nevada Gold

$2.32

-0.01 (-0.43%)

12:46
09/18/18
09/18
12:46
09/18/18
12:46
Hot Stocks
Nevada Gold signs agreement to be taken private for $2.50 per share »

Nevada Gold & Casinos…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNST

Constellation Pharmaceuticals

$7.16

-0.49 (-6.41%)

12:46
09/18/18
09/18
12:46
09/18/18
12:46
Conference/Events
Constellation Pharmaceuticals management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

APO

Apollo Global

$34.43

0.35 (1.03%)

, HGV

Hilton Grand Vacations

$32.44

0.07 (0.22%)

12:44
09/18/18
09/18
12:44
09/18/18
12:44
Hot Stocks
Apollo's Diamond Resorts names former Hilton Grand Vacations exec as CFO »

Apollo Global's…

APO

Apollo Global

$34.43

0.35 (1.03%)

HGV

Hilton Grand Vacations

$32.44

0.07 (0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

GOOG

Alphabet

$1,169.36

12.98 (1.12%)

, GOOGL

Alphabet Class A

$1,172.95

13.62 (1.17%)

12:42
09/18/18
09/18
12:42
09/18/18
12:42
Hot Stocks
You Tube launches new Gaming destination »

In an earlier blog…

GOOG

Alphabet

$1,169.36

12.98 (1.12%)

GOOGL

Alphabet Class A

$1,172.95

13.62 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 20

    Sep

  • 21

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 03

    Mar

UWN

Nevada Gold

$2.32

-0.01 (-0.43%)

12:40
09/18/18
09/18
12:40
09/18/18
12:40
Hot Stocks
Breaking Hot Stocks news story on Nevada Gold »

Nevada Gold trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STZ

Constellation Brands

$212.39

0.19 (0.09%)

12:40
09/18/18
09/18
12:40
09/18/18
12:40
Options
Notable activity in Constellation Brands upside calls »

Notable activity in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Oct

  • 13

    Oct

  • 28

    Oct

SEAS

SeaWorld

$30.88

-0.3 (-0.96%)

12:38
09/18/18
09/18
12:38
09/18/18
12:38
Hot Stocks
SeaWorld, former CEO settle SEC fraud charges over misleading statements »

The Securities and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:35
09/18/18
09/18
12:35
09/18/18
12:35
General news
U.S. July TIC report will get more intense scrutiny »

U.S. July TIC report will…

SEAS

SeaWorld

$30.97

-0.21 (-0.67%)

12:33
09/18/18
09/18
12:33
09/18/18
12:33
Periodicals
SeaWorld sued by SEC for lack of disclosing 'Blackfish' impact, Bloomberg says »

The SEC is suing SeaWorld…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTDOY

Nintendo

$0.00

(0.00%)

, CCOEY

Capcom

$0.00

(0.00%)

12:31
09/18/18
09/18
12:31
09/18/18
12:31
Hot Stocks
Game On: Piper says 'Fortnite' Twitch viewership fell 13% in August »

Welcome to "Game…

NTDOY

Nintendo

$0.00

(0.00%)

CCOEY

Capcom

$0.00

(0.00%)

MSFT

Microsoft

$113.34

1.15 (1.03%)

SNE

Sony

$59.75

0.47 (0.79%)

AMZN

Amazon.com

$1,952.39

44.52 (2.33%)

TCEHY

Tencent

$0.00

(0.00%)

DIS

Disney

$109.35

-0.02 (-0.02%)

ATVI

Activision Blizzard

$80.08

1.2 (1.52%)

TTWO

Take-Two

$133.81

2.31 (1.76%)

EA

Electronic Arts

$112.64

-0.05 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 24

    Sep

  • 21

    Oct

  • 28

    Oct

  • 30

    Oct

  • 03

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.